Warning

Objectives

Management of acute STEMI
“For most patients with ST elevation MI, emergency reperfusion treatment should be with primary PCI rather than with thrombolysis. If for logistical reasons it is not possible to transfer the patient to the RIE for PCI within 90 minutes travel time and there are no contra-indications, the following thrombolysis protocol should be used.”

All patients self presenting to ED or having a STEMI during hospital admission should be discussed with RIE in  first instance. Any difficult cases can be discussed with BGH cardiology team within normal hours.

RAPID THROMBOLYSIS SAVES LIVES  - "TIME IS MUSCLE"

Patients with ST Elevation Myocardial Infarction (Heart Attack) and a clear indication for thrombolysis (Clot buster) should have the drug started within 30 minutes of arrival in  Hospital.

We (doctors, porters and nurses) must all make these patients our priority.

Rapid assessment and initiation of treatment is essential prior to formal clerking.

 

EMERGENCY THROMBOLYSIS FOR STEMI - INDICATIONS

Ischaemic chest pain > 20 minutes (< 12 hours unless ongoing pain) not relieved by GTN

ECG Changes

> 1mm ST elevation in 2 contiguous limb leads
> 2mm ST elevation in 2 contiguous chest leads
LBBB – If known to be old, discuss with the Consultant

All patients usually receive (unless already given) 300mgs Aspirin and 300mgs Clopidogrel loading dose at presentation

EMERGENCY THROMBOLYSIS FOR STEMI - CONTRA-INDICATIONS

This is not exhaustive, any other co-morbidities that increase the likelihood of side effects – D/W Consultant

ABSOLUTE
  • Community delivered TNK
  • Active Internal bleeding
  • Suspected/confirmed aortic dissection
  • Prior Cerebral Haemorrhage (Consider Primary PCI)
  • Acute Pancreatitis
  • Pericarditis
  • Severe Liver Disease
  • Ischaemic CVA within 6 months
  • History of intracranial bleed, neoplasm or head trauma within 6 weeks or neurosurgery  within 1 year
RELATIVE – discuss with Consultant
  • Recent GI haemorrhage
  • Prolonged, traumatic CPR
  • Recent surgery or puncture of a non compressible artery
  • Bleeding disorders
  • Systolic Hypertension >180/110 (Rx with
  • analgesia and nitrates)
  • Pregnancy
  • Non-menstrual PV bleeding

PATIENTS ON WARFARIN or NOAC SHOULD BE DISCUSSED WITH RIE FOR PPCI

EMERGENCY THROMBOLYSIS FOR STEMI - TREATMENT

TENECTEPLASE (TNK) should be used for all appropriate ST elevation Myocardial Infarction patients. If  Thrombolysis is contra-indicated Primary Angioplasty should be considered.

TNK dosing is weight adjusted (approximate this, don’t waste time with scales) to a maximum of 10 000 units.

The dose works out to be approx. 100 units/kg – PRESCRIBE THIS AS UNITS AND AS AN IV BOLUS

Patients’ body weight
category (KGS)
TNK (Units) TNK (MG) Volume of reconstituted
solution (ML)
<60 6000 30 6
≥60 to <70 7000 35 7
≥70 to <80 8000 40 8
≥80 to <90 9000 45 9
≥90 1000 50 10


The required dose should be administered as a single intravenous bolus over approximately 10 seconds.
A pre- existing intravenous line may be used for administration of Tenecteplase in 0.9 % sodium chloride
solution only. Tenecteplase is incompatible with dextrose solution.

Send off bloods for urgent coagulation screen, INR (if on Warfarin), FBC and biochemistry prior to administration of thrombolytic. DO NOT WAIT FOR THE RESULTS.

Tenecteplase should be administered with caution in people aged 75 years or over due to higher bleeding risk.
IF THE PATIENT IS ON WARFARIN OR NOAC THEY SHOULD BE DISCUSSED WITH RIE FOR PPCI

EMERGENCY THROMBOLYSIS FOR STEMI - TNK REGIMEN

FONDAPARINUX/HEPARIN DOSING – COMPLEX READ CAREFULLY

TNK administration is followed immediately by:

Fondaparinux 2.5mgs IV Bolus unless known Heparin induced Thrombocytopenia (Discuss with Haematologist on-call)

CONTRA-INDICATIONS to Fondaparinux include:

Active clinically significant bleeding
Acute Bacterial Endocarditis
Severe renal impairment - Creatinine clearance < 20ml/min

CAUTIONS

Abnormal clotting, including INR > 1.5 Discuss with haematologist on call
Platelet count < 50 x 10 9/L

If no contraindications, continue Fondaparinux 2.5mgs subcutaneously once daily until discharge or up to a
maximum of 8 days treatment.

FONDAPARINUX/HEPARIN DOSING – COMPLEX READ CAREFULLY

If S/C Fondaparinux is contra-indicated commence unfractionated Heparin IV - 20 000 units in 20ml neat at a starting rate of 1200 units/hr (1.2mls/hr) for 48 hours. No further bolus dose should be given.

Check APTT at 6 hours and adjust the infusion rate to achieve an APTT (ratio) of 1.5 - 2.5.

If patients have received TNK/5000 units bolus of unfractionated Heparin in the community, omit the initial IV Fondaparinux and continue with S/C Fondaparinux (administering 6 hours after the community dose) or IV unfractionated Heparin as above . Patients who have received TNK/5000UNITS unfractionated Heparin in the community can receive Fondaparinux if there are no contra-indications.

Editorial Information

Last reviewed: 30/04/2020

Next review date: 31/12/2025

Author(s): O'Neary P.

Approved By: Clinical Governance & Quality

Reviewer name(s): Donaldson G.